Global Med Technologies(R), Inc. and Cerner Announce Strategic Alliance
April 09 2008 - 9:00AM
PR Newswire (US)
Blood Bank Software to Complement Renowned Laboratory Information
System DENVER, April 9, 2008 /PRNewswire-FirstCall/ -- Global Med
Technologies(R), Inc. (OTC:GLOB) (BULLETIN BOARD: GLOB) , an
international e-Health, medical information technology company,
today announced that its Wyndgate Technologies(R) (Wyndgate)
division has formed a strategic marketing alliance with Cerner
Corporation (Cerner) (NASDAQ:CERN), a leading provider of
healthcare information technology (HIT) solutions. Cerner will
market Wyndgate's comprehensive blood management software modules
in conjunction with Cerner's universally known Millennium Suite
laboratory information system (LIS). Terms of the agreement were
not disclosed. (Logo:
http://www.newscom.com/cgi-bin/prnh/20040226/GLOBALMEDLOGO) "We are
pleased that Cerner Corporation has selected Wyndgate blood
management systems to complement its Millennium Suite," said Thomas
F. Marcinek, President and COO of Global Med Technologies. "This
strategic alliance will offer healthcare organizations feature-rich
blood management solutions which will interface with Cerner's
laboratory information systems, promoting increased efficiencies in
blood banks, as well as supporting patient safety. The
Cerner-Wyndgate affiliation further strengthens Wyndgate's position
in the domestic and international blood management marketplace.
Today Wyndgate's products and services manage, annually, more than
eight million blood components, representing over 27% of the U.S.
blood supply." About Cerner Corporation Cerner is a major U.S.
supplier of healthcare information technology solutions that
optimize clinical and financial outcomes. Around the world,
healthcare organizations ranging from single-doctor practices to
entire countries turn to Cerner for its powerful and intuitive
solutions. Cerner offers clients a dedicated focus on healthcare,
an end-to-end solution and service portfolio, and proven market
strengths. Cerner Millennium is a healthcare information technology
computing platform helping health professionals elevate safety,
quality and efficiency. About Global Med Technologies, Inc. Global
Med Technologies(R), Inc. is an international e-Health medical
information technology company providing information management
software products and services to the healthcare industry. Its
Wyndgate Technologies(R) division is a leading supplier of
information management systems to U.S. and international blood
centers and hospital transfusion centers. Each year, Wyndgate's
products and services manage more than eight million blood
components, representing over 27% of the U.S. blood supply.
Wyndgate's products are also being used in Canada, Africa, and the
Caribbean. Wyndgate's software provides Vein-to-Vein(R) tracking
from donor collection to patient transfusion through its Donor
Doc(TM) interactive donor health history questionnaire, ElDorado
Donor(TM) and SafeTrace(R) donor management systems, to its
SafeTrace Tx(R) advanced transfusion management system. Global
Med's PeopleMed(R), Inc. subsidiary provides custom software
validation, consulting and compliance solutions to hospitals and
blood centers. PeopleMed's in-depth knowledge of Wyndgate's
products and the blood banking industry results in cost-effective
validation services, which leads to more efficient software
implementations and upgrades for our customers. For more
information about Global Med's products and services, please call
800-WYNDGATE or visit http://www.globalmedtech.com/,
http://www.peoplemed.com/ and http://www.wyndgate.com/. This news
release may include statements that constitute forward-looking
statements, usually containing the words "believe," "estimate,"
"project," "expects" or similar expressions. These statements are
made pursuant to the safe harbor provisions of the Private
Securities Litigation Reform Act of 1995. Forward-looking
statements inherently involve risks and uncertainties that could
cause actual results to differ materially from the forward-looking
statements. By making these forward-looking statements, the Company
undertakes no obligation to update these statements for revisions
or changes after the date of this news release.
http://www.newscom.com/cgi-bin/prnh/20040226/GLOBALMEDLOGO
http://photoarchive.ap.org/ DATASOURCE: Global Med Technologies,
Inc. CONTACT: Michael I. Ruxin, M.D. of Global Med Technologies,
Inc., +1-303-238-2000, ; or investors, Paul Holm, President of
portfoliopr.inc, +1-212-888-4570, , for Global Med Technologies,
Inc. Web site: http://www.globalmedtech.com/
http://www.peoplemed.com/ http://www.wyndgate.com/
Copyright